LILLIAN NICKS: Open Payments
NPI 1558641670 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,971 in 21 payments from 9 companies in 2025. Trend: 2023 $1,114 · 2024 $1,678 · 2025 $1,971
Long term medical supply or device loan: $1,000Food & beverage: $697Consulting: $175Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $1,000 |
| Incyte Corporation | 2 | $196 |
| Alexion Pharmaceuticals, Inc. | 1 | $175 |
| Janssen Biotech, Inc. | 1 | $122 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $120 |
| GlaxoSmithKline, LLC. | 1 | $113 |
| Janssen Scientific Affairs, LLC | 1 | $94 |
| AstraZeneca Pharmaceuticals LP | 1 | $89 |
| Astellas Pharma Global Development | 1 | $62 |
Products named: KISQALI, RYBREVANT, ULTOMIRIS, ZYNLONTA, OJJAARA, Niktimvo, Xtandi.
Industry payments across SC — which companies pay providers there.
